The global radiation injury drugs market is anticipated to grow at a significant CAGR during the forecast period. Radiation injury is defined as the damage of tissues due to exposure of ionizing radiation. The ionizing radiation given in large dose may injure the healthy human cells and even result in acute illness leading to decrease in the production of blood cells and harm the gastrointestinal tract. It also results in the damage to cardiovascular health, blood vessels, brain and especially skin. The major factor attributable to the market growth include the high prevalence of cancer patients globally who further opt for the radiation therapy. For instance, as per the International Agency for Research on Cancer, in 2020, there were 19.3 million cases of cancer globally and 10 million died due to cancer. Thus, this surge in the cancer patients is likely to drive the global radiation injury drugs market growth.
In addition to this, various enduring research and products under clinical trials are the factors for the growth of radiation injury drug market. For instance, BioMimetix drug BX-001 is under clinical phase II trial and is used for the patients with high-grade glioma. However, the drug is also used to provide protection against the damage or injury done by the radiation therapy. Another key factor that significantly impacts the market growth for these drugs include the fact that the radiation injury can cause reduced production of sperm and egg count in male and female respectively.
To Request a Sample of our Report on Radiation Injury Drugs Market: https://www.omrglobal.com/request-sample/radiation-injury-drugs-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Amgen Inc., and BioMimetix JV, LLC, among others.
Radiation Injury Drugs Market Report by Segment
By Type
- Aerosurf
- BMX-001
- C-2E2
- C-2E5
- Des-Asp Angiotensin 1
- DG-3
- Others
By Application
- Ambulatory Surgical Centers
- Hospitals and Clinics
- Others
A full Report of Radiation Injury Drugs Market is Available @ https://www.omrglobal.com/industry-reports/radiation-injury-drugs-market
Radiation Injury Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
